121 related articles for article (PubMed ID: 20634065)
1. Inhibitors of osteoclastogenesis from Lawsonia inermis leaves.
Cuong NX; Nhiem NX; Thao NP; Nam NH; Dat NT; Anh Hle T; Huong le M; Kiem PV; Minh CV; Won JH; Chung WY; Kim YH
Bioorg Med Chem Lett; 2010 Aug; 20(16):4782-4. PubMed ID: 20634065
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial galloylated alkylphloroglucinol glucosides from myrtle (Myrtus communis).
Appendino G; Maxia L; Bettoni P; Locatelli M; Valdivia C; Ballero M; Stavri M; Gibbons S; Sterner O
J Nat Prod; 2006 Feb; 69(2):251-4. PubMed ID: 16499325
[TBL] [Abstract][Full Text] [Related]
3. Flavanone glycosides from viscum coloratum and their inhibitory effects on osteoclast formation.
Han N; Huang T; Wang YC; Yin J; Kadota S
Chem Biodivers; 2011 Sep; 8(9):1682-8. PubMed ID: 21922656
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory acylphloroglucinol derivatives from Hops (Humulus lupulus).
Bohr G; Gerhäuser C; Knauft J; Zapp J; Becker H
J Nat Prod; 2005 Oct; 68(10):1545-8. PubMed ID: 16252923
[TBL] [Abstract][Full Text] [Related]
6. Megastigmane and phenolic components from Laurus nobilis L. leaves and their inhibitory effects on nitric oxide production.
De Marino S; Borbone N; Zollo F; Ianaro A; Di Meglio P; Iorizzi M
J Agric Food Chem; 2004 Dec; 52(25):7525-31. PubMed ID: 15675799
[TBL] [Abstract][Full Text] [Related]
7. Formylated phloroglucinols from Eucalyptus loxophleba foliage.
Sidana J; Singh S; Arora SK; Foley WJ; Singh IP
Fitoterapia; 2011 Oct; 82(7):1118-22. PubMed ID: 21803129
[TBL] [Abstract][Full Text] [Related]
8. 5-O-glucosyldihydroflavones from the leaves of Helicia cochinchinensis.
Morimura K; Gatayama A; Tsukimata R; Matsunami K; Otsuka H; Hirata E; Shinzato T; Aramoto M; Takeda Y
Phytochemistry; 2006 Dec; 67(24):2681-5. PubMed ID: 16973192
[TBL] [Abstract][Full Text] [Related]
9. Tomentosones A and B, hexacyclic phloroglucinol derivatives from the Thai shrub Rhodomyrtus tomentosa.
Hiranrat A; Mahabusarakam W; Carroll AR; Duffy S; Avery VM
J Org Chem; 2012 Jan; 77(1):680-3. PubMed ID: 22085112
[TBL] [Abstract][Full Text] [Related]
10. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways.
Hu JP; Nishishita K; Sakai E; Yoshida H; Kato Y; Tsukuba T; Okamoto K
Eur J Pharmacol; 2008 Feb; 580(1-2):70-9. PubMed ID: 18083161
[TBL] [Abstract][Full Text] [Related]
11. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
12. New antimicrobial terpenoids and phloroglucinol glucosides from Syzygium szemaoense.
Xu W; Tan J; Mu Y; Zheng D; Huang X; Li L
Bioorg Chem; 2020 Oct; 103():104242. PubMed ID: 32916541
[TBL] [Abstract][Full Text] [Related]
13. A new phenylpropanoid glucoside from the aerial parts of Lygodium japonicum.
Duan YH; Dai Y; He RR; Kurihara H; Li YL; Yao XS
J Asian Nat Prod Res; 2012; 14(3):286-92. PubMed ID: 22251217
[TBL] [Abstract][Full Text] [Related]
14. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.
Ren W; Li XH; Chen BD; Wooley PH
J Orthop Res; 2004 Jan; 22(1):21-9. PubMed ID: 14656655
[TBL] [Abstract][Full Text] [Related]
15. Grevillosides A-F: glucosides of 5-alkylresorcinol derivatives from leaves of Grevillea robusta.
Yamashita Y; Matsunami K; Otsuka H; Shinzato T; Takeda Y
Phytochemistry; 2008 Nov; 69(15):2749-52. PubMed ID: 18812248
[TBL] [Abstract][Full Text] [Related]
16. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
Wattel A; Kamel S; Prouillet C; Petit JP; Lorget F; Offord E; Brazier M
J Cell Biochem; 2004 May; 92(2):285-95. PubMed ID: 15108355
[TBL] [Abstract][Full Text] [Related]
17. Tyrosyl-DNA Phosphodiesterase I Inhibitors from the Australian Plant Macropteranthes leichhardtii.
Tian LW; Feng Y; Tran TD; Shimizu Y; Pfeifer T; Forster PI; Quinn RJ
J Nat Prod; 2015 Jul; 78(7):1756-60. PubMed ID: 26149757
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
20. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
Merle B; Itzstein C; Delmas PD; Chenu C
J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
